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ABSTRACT: Implantation of biomedical devices is often followed by bacterial
infections that may seriously affect implant functionalities and lead to their failure.
In the context of bacterial resistance to antibiotics, which is a growing problem
worldwide, new strategies that are able to overcome these problems are needed. In
this work, we introduce a new formulation of hyaluronic acid (HA)-based
antimicrobial material: HA hydrogels loaded with polyarginine (PAR), a
polycationic antibiotic substitute. The loading is possible through electrostatic
interactions between negatively charged HA and positively charged PAR. Such
hydrogels absorb high quantities of PAR, which are then gradually released from
the hydrogel. This original system provides a long-lasting antibacterial effect on an
in vitro model of repetitive infection, thus demonstrating a strong potential to fight
multiple rounds of infections that are resistant to antibiotic treatment. In addition, HA-PAR hydrogels could be deposited onto/into
medical devices such as wound dressings and mesh prostheses used in clinical applications. Finally, we performed first in vivo tests of
hydrogel-coated mesh materials to verify their biocompatibility in a rat model, which show no difference between control HA
hydrogel and PAR-loaded hydrogel in terms of inflammation.
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■ INTRODUCTION
Implantation of medical devices is often followed by bacterial
infections that may seriously affect implant functionalities and
even lead to their failure.1 The rate of medical device-related
infections varies from 5−8% for central venous catheters to
25−50% for heart-assist devices.2 These infections are mostly
induced by Staphylococcus epidermidis, Pseudomonas aeruginosa,
Staphylococcus aureus, and enterobacteria such as Escherichia
coli.3 The bacteria adhere to materials that promote formation
of biofilms, which are composed of bacteria in a hydrated
polymeric matrix of their own synthesis.4,5
Conservative approaches to prevent or fight the infection
include using of antibiotics (locally or systemically) and
antiseptics (locally).6 New approaches such as materials
containing antibiotics that are applied locally during the
surgery are being developed. One of the approaches to fight
the infection locally consists in using antibiotic-loaded collagen
sponges that are now widely used for different clinical
applications.7−9 For instance, Musella et al. described insertion
of a gentamicin-treated collagen tampon adjacent to a
polypropylene (PP) mesh used for repairing groin hernias,
which is reduced by > 6-fold the rate of wound infections.7
More recently, hyaluronic acid (HA) hydrogel coatings to
protect implanted biomaterials in orthopedics, trauma, and
maxillofacial surgery were developed. Such hydrogels can be
loaded with antibiotics and applied to the implant surface at
the time of surgery.10 Currently, new antibiotic-releasing
systems are being developed, for instance, a pH-responsive
hydrogel obtained by reacting oxidized dextran with amino-
glycoside and an ornidazole has been recently described.11
However, bacteria resistance to antibiotics is a growing
problem worldwide.12 Hence, antimicrobial agents, which are
able to overcome antibiotic resistance problem, are needed.
One of the most common antimicrobial agent family is based
on metals such as silver, gold, copper, and zinc.13 They can be
used as surface coating or embedded into hydrogels as
nanoparticles. However, there remains uncertainties about
safety of metallic nanoparticles such as silver as they have
potential secondary effects and elevated cytotoxicity at high
concentrations.14 Antimicrobial peptides (AMPs) are another
category of emerging therapeutic agents.15 Despite recent
progress, scale-up in their production remains a main
challenge. Other molecules/substances recently used as
antibiotic substitutes include pyrrolidinium ionic liquids,16
polyhexamethylene guanidine phosphate,17 hinokitiol,18 and
https://dx.doi.org/10.1021/acsami.9b23140
curcumin.19 The exhaustive list of antibiotic substitutes used to
functionalize the hydrogels can be found in specialized
reviews.20−22
Polyarginine (PAR) is a polycationic polypeptide presenting
antimicrobial activity in solution, with minimum inhibitory
concentration (MIC) depending on the PAR length.23 It can
be produced by polymerization that makes PAR more
profitable compared to AMPs. We have previously described
thin films made of PAR and HA, constructed by layer-by-layer
assembly,24 which demonstrated antimicrobial and anti-
inflammatory properties.23,25,26 Interestingly, antimicrobial
activity of PAR-containing layer-by-layer films was only
observed for PAR of 30 arginine residues (PAR30). Moreover,
this activity was demonstrated only when PAR30 was
associated to HA and did not work for other polyanions
(e.g., alginate). This property is probably related to the strong
diffusion capacity of PAR30 chains in (PAR30/HA) multi-
layers compared to their diffusion ability in the other films.26
HA is a polyanionic polysaccharide composed of a repeating
disaccharide unit of (1,4)-glucuronic acid-β (1,3)-N-acetylglu-
cosamine (GlcNAc), and it is naturally present in the
extracellular matrix of vertebrate tissues.27,28 Synovial fluid,
vitreous humor of the eye, and hyaline cartilage are especially
rich in HA. HA is known to promote wound healing, is
biocompatible, and already used for multiple biomedical
applications such as dermal injections, osteoarthritis treatment,
eye surgery, and wound regeneration.29 HA is also known to
have antifouling properties, which reduces bacterial adhe-
sion.30−32 In one study, HA was grafted with AMP nisin in
order to elaborate an antimicrobial biopolymer combining
properties of nisin and HA.33
Another advantage of HA is the possibility to form hydrogels
with tunable properties via cross-linking, which allows to adapt
them to a given application and control HA degradation rate.34
Among different cross-linkers, BDDE (1,4-butanediol digly-
cidyl ether) is by far the most commonly employed nowadays,
for example, it is used in the production of majority of dermal
fillers for esthetic purposes.35,36 The advantage of BDDE as a
cross-linking agent is that at high pH, it cross-links via hydroxyl
groups,36 while leaving negatively charged carboxyl groups
available for complexation with positively charged molecules,
for instance, with PAR.
In this work, we introduce a new formulation of HA-based
antimicrobial material: HA hydrogels cross-linked with BDDE
and loaded with PAR. We demonstrate that HA hydrogels can
be loaded with PAR of different lengths, and some conditions
provide a long-lasting antibacterial effect because of a gradual
release of PAR from the hydrogel. Thus, they could be
potentially used to fight persistent infections that are difficult
to eradicate.37
The hydrogels were also deposited onto medical devices
such as wound dressings and mesh prostheses used for hernia
repair. Deposition of the HA-PAR hydrogels onto these
materials is simple and shows efficient antimicrobial properties.
This represents an important step because meshes used for
hernia repair present a high risk of postoperative infection. For
instance, up to 8% of up to 8% of ventral hernial repairs by
meshes become infected and may require excision.38
Antibacterial HA-PAR hydrogels, alone or deposited on
medical devices, can be used in the future to treat infected
wounds, prevent infections related to implantation, and
eradicate persistent infections because of PAR gradual release.
■ MATERIALS AND METHODS
Materials. Poly(L-arginine hydrochloride) (PAR) was purchased
from Alamanda Polymers, USA. The different PAR polymers used
differ by the numbers of arginine residues per chain: PAR10 (MW =
1.9 kDa), PAR30 (MW = 5.8 kDa), and PAR200 (MW = 38.5 kDa).
HA (MW = 823 kDa) used as the polyanion was purchased from
Lifecore Biomed (USA). Tris(hydroxymethyl)-aminomethane (Tris),
butanediol diglycidyl ether (BDDE), thiazolyl blue tetrazolium
bromide (MTT), and Mueller Hinton (MH) broth medium were
purchased from Merck (Germany). DMEM (Dulbecco’s modified
Eagle medium) and 100× penicillin−streptomycin were purchased
from Dominique Dutscher (France), and fetal bovine serum (FBS)
was purchased from Gibco/ThermoFicher Scientific (France).
Gynecare Gynemesh PS (Ethicon, USA) was kindly provided by Dr
Nicolas Sananes.
Preparation of HA Hydrogels. To prepare HA hydrogels, 1.5
mL of 2.5% HA (MW = 823 kDa) solution in NaOH (0.25 M) was
mixed with 20% BDDE (v/v) and poured into a 35 mm diameter
Petri dish. The mixture was allowed to cross-link at room temperature
for 72 h (Figure 1A). The hydrogel was further cut, most of the time,
into 4 mm discs using a circle cutter, and rinsed in Tris 10 mM/NaCl
0.15 M buffer (further referred to as Tris/NaCl buffer). One fast 1
min rinsing and a longer 1 h rinsing were performed. After this
procedure, 4 mm diameter discs have swollen and became 6 mm
diameter discs. Initially, HA of several molecular weights, as well as
different concentrations of both HA and BDDE, was tested.
Conditions allowing formation of a free-standing, handable optimal
gel were finally selected and are now described in this study.
Rheological Characterization of HA Hydrogels. Rheological
measurements were performed in HA−BDDE mixture using a
Kinexus rheometer and d = 40 mm cone geometry. Briefly, 1.2 mL
of freshly mixed HA−BDDE solution was deposited between the cone
and the plate, and gelation was followed at 25 °C for 72 h at a
frequency of 1 Hz. To avoid evaporation, the solvent trap was used.
Loading and Release of PAR. To load PAR into the hydrogels,
the discs were immersed in PAR solution in Tris/NaCl buffer and
incubated for 24 h at room temperature on a moving plate (Figure
1B). For 6 mm discs in the 24-well plate, 0.5 mL of PAR solution was
used. After incubation, the discs were rinsed with Tris/NaCl buffer
(one quick and one long rinsing, 5 min and 1 h, respectively).
Figure 1. Preparation of HA-PAR hydrogel discs. (A) Production of
HA hydrogel discs: HA (1.5 mL) and BDDE well-mixed solution is
poured into a Petri dish and allowed to cross-link at room
temperature for 72 h. The hydrogel was further cut into the discs
of required size using a circle cutter. (B) HA hydrogel discs loading
with PAR for 24 h, followed by rinsing in Tris/NaCl buffer. (C)
Confocal microscopy imaging of hydrogel discs.
For PAR release experiments, discs loaded with fluorescein
isothiocyanate-conjugated PAR (PAR-FITC, produced in the
laboratory as described previously23) were incubated at 37 °C with
respective solution (NaCl 1 M, MH medium or DMEM
supplemented with 10% FBS and 1% antibiotics). The release
quantification of PAR-FITC in solution was performed by measuring
the fluorescence of the supernatant with a spectrofluorimeter (SAFAS
Xenius XC spectrofluorimeter, Monaco) with an excitation/emission
wavelength of 488/517 nm.
Confocal laser scanning microscopy (CSLM, LSM 710 microscope,
Zeiss, Heidelberg, Germany) was also used to characterize PAR
loading and release. To characterize PAR loading, the discs were
incubated with PAR-FITC as described above, and then disc X × Y
cross-cut images were taken in the middle of the discs (Figure 1C).
Fourier-Transform Infrared Spectroscopy. Fourier-transform
infrared spectroscopy (FTIR) experiments were performed on a
Vertex 70 spectrometer (Bruker, Germany) using a DTGS detector.
Spectra were recorded in the Attenuated total reflection (ATR) mode
using single reflection diamond ATR by averaging 128 interferograms
between 600 and 4000 cm−1 at 2 cm−1 resolution using Blackman−
Harris three-term apodization and Bruker OPUS/IR software (version
7.5). HA gels were prepared in deuterated solution using the standard
protocol, incubated in Tris/NaCl deuterated solution in the absence
or the presence of 1 mg·mL−1 PAR and dried before the
measurement. The normalization was performed on the entire spectra
recorded between 800 and 4000 cm−1 by applying the min/max
normalization of OPUS 7.5 software. This normalization allows to
compare spectra with each other when the optical layer thickness
substantially varies. As the diffusion of PAR inside HA gel leads to its
contraction, FTIR spectra of HA/PAR gels have higher intensities in
comparison to the HA gel because of the probing of more material on
the surface. Thus, the normalization of FTIR spectra was applied by
attributing to the highest peak of the HA with the value of 1. This
normalization allows the comparison of the spectra for the same
quantity of HA probed by the IR source. As in each sample, the
polysaccharide peaks have the highest intensity, and the normalization
is obtained toward the quantity of HA probed by the IR source.
Fluorescence Recovery after Photobleaching Experiments.
Fluorescence recovery after photobleaching (FRAP) experiments
were performed on HA hydrogels incubated with 0.5 mg·mL−1 of
fluorescently labeled PAR and immersed in Tris/NaCl buffer. One
circular region (95 μm in radius in an image of 850 μm × 850 μm)
was exposed for 64.4 s to the light of a laser set at its maximum power
(λ = 488 nm). Then, the recovery of fluorescence in the bleached area
was followed over time. Observations were carried out with the
confocal microscope using a 10× objective. At the same time, four
equally sized circular reference areas outside of the bleached area were
monitored. The intensities in these areas were used to normalize the
intensity in the bleached area, so that bleaching because of image
acquisition was accounted for.
Antibacterial Assays. S. aureus (ATCC 25923), E. coli (ATCC
25922), and P. aeruginosa (ATCC 27853) strains were used to assess
the antibacterial properties of the test samples. Bacteria were
precultured aerobically at 37 °C in a MH broth medium, pH 7.3.
For this, one colony from the previously prepared agar plate with
streaked bacteria was transferred to 10 mL of MH medium and
incubated at 37 °C. Overnight culture was adjusted to OD620nm =
0.001 (approximately 8 × 105 CFU.mL−1) by diluting in MH and
added to the wells of a 24-well plate containing d = 6 mm HA
hydrogels loaded with different concentrations of PAR and sterilized
with UV for 15 min. Antibacterial effect of HA-PAR hydrogels was
quantified by measuring OD620nm after 24 h of incubation at 37 °C on
a moving plate (Figure S1). In repetitive culture experiments, bacterial
suspension (OD620nm = 0.001) was replaced every 24 h.
In Vitro Cytotoxicity Tests. The Balb/3T3 (ATCC CCL163)
mouse embryonic fibroblast cell line was cultured at 37 °C in DMEM
with 10% of FBS and 1% of penicillin−streptomycin (further referred
to as “DMEM”). The cytotoxicity tests were performed according to
ISO 10993-5. For the direct cytotoxicity test, we used 4 mm diameter
discs, which swell and become ∼6 mm diameter when placed in Tris/
NaCl buffer. The discs, loaded or not with PAR, were sterilized with
UV for 15 min and placed onto ∼80% confluent layer of BALB/3T3
cells (passage 2 to 15) cultured in a 24-well plate (Figure S2). After
24 or 48 h at 37 °C, phase contrast images were taken around and
under the discs to evaluate the cell morphology. The images were
captured using an Olympus CDX41 microscope (Olympus Corpo-
ration, Japan) with an Infinity 2 camera and Infinity Analyze software.
Then, hydrogel discs were removed, and MTT test was performed in
order to measure cell metabolic activity. For MTT assay, the cells
were incubated for 3 h in 0.2 mg·mL−1 MTT-containing cell culture
medium. The medium was then removed, and formazan was dissolved
in dimethyl sulfoxide (0.5 mL per well of a 24-well plate). Absorbance
of resulting solutions was measured at 570 nm using the
spectrophotometer.
Hydrogel Deposition onto Nonwoven/mesh Materials. To
deposit the hydrogels onto materials (Medicomp, a nonwoven fabric
used for wounds disinfection and GYNECARE GYNEMESH PS
Nonabsorbable PROLENE Soft Mesh), HA−BDDE solution (50 μL)
was deposited on 12 mm diameter fabric or mesh piece and allowed
to cross-link as previously described.
In Vivo Biocompatibility. Ten 8-week-old male Wistar rats
(300−400 g in weight), provided by a certified breeding center
(Charles River, France), were used for this study. The animals were
received at the CREFRE (US 006/CREFRE-Inserm/UPS/ENVT)
animal supplier (no. A31555010 issued December 17, 2015).
Protocols were submitted to the CREFRE ethics committee with
approval, in accordance with the European directive (DE 86/609/
CEE; modified DE 2003/65/CE) for conducting animal experiments.
One week of acclimatization was respected. The animals were housed
in ventilated cages with a double level (two animals per cage
according to European standards). The animals were carefully
monitored (behavior and food intake) and were weighed weekly
throughout the experiment. The 10 rats received each two round
implants (diameter of 1 cm), one implant on left side and one implant
on right side. In total, there were five implantations of dried and
autoclaved hydrogels deposited onto mesh materials for each of the
following conditions: (i) HA-only hydrogels; (ii) HA hydrogels
loaded with PAR10 at 0.1 mg·mL−1; (iii) HA hydrogels loaded with
PAR30 at 0.05 mg·mL−1; (iv) HA hydrogels loaded with PAR30 at
0.1 mg·mL−1.
The rats were induced by isoflurane 4% and maintenance of 2%.
Each rat was placed in a prone position on a heated pad. After shaving
and scrubbing with betadine, two 20 mm dorsal incisions were made
over the thoracolumbar area, one on the right side and one on the left
side. One scaffold was inserted at both sides into subcutaneous
pockets. All the incisions were closed with Vicryl 3-0. All rats received
buprenorphine (0.6 mg/kg) injected subcutaneously twice per day for
5 days. All animals survived the duration of the study with no adverse
effects. Euthanasia were performed after 14 days. The animals were
first anesthetized with the isoflurane device and masked and then
slowly injected with an overdose of pentobarbital (150 mg/kg) in the
intraperitoneal route. After the expiration of the animal death, the
implants with surrounding tissue were explanted and collected to
perform histology.
For histological analysis, the samples were fixed in 4% formalin.
Macroscopic sections were embedded in paraffin. Five micrometer
thick sections were stained with hematoxylin−eosin−saffron. For each
sample, microscopic optical analysis was realized with software
NDP.view2 (Hamamatsu, Massy, France) after slides scanning
(NanoZoomer, Hamamatsu) with the following criteria: semi-
quantitative assessment of acute inflammation, chronic inflammation,
fibroblastic reaction, edema, fibrosis, angiogenesis, and periprosthetic
histiocytic reaction.
Statistical Analysis. Rheology, loading/release, FRAP, antibacte-
rial assays, and cytotoxicity test experiments were performed at least
three times. Either representative results or averages from three
independent experiments are shown in the figures. The data were
processed by using SigmaPlot (Systat Software Inc., USA). One-way
ANOVA on the Ranks test was performed to evaluate statistical
significance in the cytotoxicity assay.
■ RESULTS AND DISCUSSION
HA Hydrogel Formation and Disc Model. HA hydrogel
gelation kinetics is followed in Figure 2A through macroscopic
observations. At 24 h, the gelation is starting, and after 48 h,
the hydrogel is in place. These qualitative observations were
confirmed by rheological monitoring of changes in viscoelastic
properties over time (Figure 2B). According to the graph,
about 40 h was required to reach a plateau. For commodity
reasons, the hydrogels were cross-linked for 72 h (over a week-
end) before being cut to discs of different sizes (Figure 2C).
Then, after rinsing and incubation in Tris/NaCl buffer, the gels
swelled about two times (weight) (Figure 2D). For experi-
ments in 24-well plates, 6 mm diameter and ∼1 mm height
discs were used.
PAR Loading and Release from HA Hydrogels. To
study loading of PAR in the hydrogels, PAR of three different
chain lengths were used: PAR10, PAR30, and PAR200 (10, 30
and 200 arginine residues, respectively). For loading, hydrogels
were incubated with PAR solutions prepared in Tris/NaCl
buffer for 24 h. Shorter loading time (3 h) led to PAR loading
on the disc periphery, while the center remained unloaded, as
demonstrated with fluorescently labeled PAR (PAR-FITC)
(Figure S3A,B).
PAR loading into HA hydrogels was also characterized by
FTIR. The spectra (Figure S3C) show an amide I band at
1645 cm−1, due to the carbonyl group of amide bonds of both
HA and PAR, and saccharide peaks at 1040 and 1080 cm−1,
attributed to C−O bond stretching.39,40 By comparing HA gels
before and after incubation with PAR30 solutions, an increase
of the amide I peak is observed with a shifting from 1614 to
1626 cm−1 because of the contribution of the amide I band of
PAR. Moreover, an inversion of the intensities of the
polysaccharide peaks was observed with PAR-loaded hydro-
gels. This is explained by the influence of the carboxylic group
state of HA on the hydrogen bond network, as reported by
Rinaudo and co-workers.41 The presence of PAR led to a
higher contribution of 1080 cm−1 in comparison to 1040 cm−1
as reported for HA in the acidic form. This is probably related
to the electrostatic interactions between positively charged
arginine moieties of PAR and negatively charged carboxylic
groups of HA. This suggests, together with fluorescent
observations of PAR loading (Figure S3A,B), that the loading
of PAR in HA hydrogel was effective.
An example of a disc loaded with PAR30-FITC for 24 h is
shown in Figure 3A,B, where the disc morphology is visualized
by confocal microscopy. The disc is about 6 mm in diameter
and 1 mm high, giving a volume of approximately 0.03 cm3 or
30 μL and almost homogeneously loaded with PAR30-FITC,
Figure 2. HA hydrogel preparation and characterization. (A)
Monitoring of the HA gelation when BDDE is added to produce
the hydrogel. (B) Rheological characterization of HA-BDDE hydrogel
formation by monitoring elastic and viscous moduli as a function of
time. Gelation was followed at 25 °C for 72 h at a frequency of 1 Hz.
The experiment was repeated three times. (C) Production of hydrogel
discs of different sizes. (D) Hydrogel in NaOH 0.25 M (d = 18 mm
after cutting) swelling in Tris/NaCl buffer.
Figure 3. HA hydrogel loading with PAR. Confocal microscopy
images of hydrogel discs incubated in 0.5 mg·mL−1 PAR30-FITC:
cross-cuts in Z (A) and3D reconstruction (B). (C) Confocal
microscopy images and fluorescence intensity profiles of HA
hydrogels incubated in 0.5 mg·mL−1 PAR10-FITC.
although a higher fluorescence intensity on the disc periphery
can be monitored.
Similar loading profile was observed for PAR10, while
PAR200 chains mostly remained on the disc periphery and did
not diffuse after 24 h to the center of the hydrogel (Figure 3C),
which is in line with our previous observations, regarding the
mobility of longer PAR chains in the PAR/HA polyelectrolyte
multilayer:23 PAR200 was less mobile, while PAR30 showed
intermediate mobility and PAR10 being the most mobile, as
determined by FRAP experiments for multilayer films. Similar
conclusions can be drawn here from fluorescence recovery
curves determined from FRAP measurements and performed
with loaded hydrogels (Figure 3D).
Total amounts of PAR contained in the hydrogels were
estimated by incubation of hydrogels loaded with fluorescently
labeled PAR in concentrated NaCl to promote PAR release.
After 72 h at 37 °C in NaCl 1 M, the release was almost
complete for PAR10 and close to 80% for PAR30 and PAR200,
according to the confocal microscopy images (Figure 4A). The
percentage of PAR remaining in the hydrogel discs after 72 h
of incubation was measured with image processing; 100%
corresponds to fluorescence intensity before release. Then,
percentage of remaining PAR after NaCl 1 M incubation was
determined to obtain a value of released PAR: about 97, 78,
and 78% for PAR10, PAR30, and PAR200, respectively.
Incomplete release of PAR30 and PAR200 correlates with
lower mobility demonstrated by FRAP experiments (Figure
3D). Then, amounts of PAR-FITC released were quantified by
measuring fluorescence intensity of the supernatant by
spectrofluorimetry and referring to a calibration curve. The
results show that the discs incubated in 0.5 mg·mL−1 PAR
solutions released about 212 μg of PAR10-FITC, 157 μg of
PAR30-FITC, and 91 μg of PAR200-FITC after 72 h in NaCl
1 M (Figure 4B). When correcting the released quantities to
100%, it gives 218, 201, and 117 μg of loaded PAR10-FITC,
PAR30-FITC, and PAR200-FITC, respectively. Disc volume is
approximately 30 μL, so the discs contain about 7.3 mg·mL−1
of PAR10, 6.7 mg·mL−1 of PAR30, and 3.9 mg·mL−1 of
PAR200. Lower quantity of PAR200 in the hydrogels can be
explained by its incomplete loading with most of PAR200
remaining on the disc periphery (Figure 3C).
Figure 4. Release of PAR in NaCl and in culture media. HA discs were incubated with 0.5 mg·mL−1 of three different FITC-conjugated PAR for 24
h. The discs were rinsed and then incubated for 72 h in NaCl 1 M, MH, or DMEM. (A) Confocal microscopy observations: percentage of PAR
remaining after 72 h is indicated. (B) Quantification by spectrofluorimetry of PAR release after 72 h in NaCl 1 M. The graphs represent averages
from three independent experiments, and error bars represent standard deviations. (C) Confocal microscopy images of the discs before and after
incubation with MH and DMEM. (D) and (E) Percentage of released PAR in MH and DMEM, where 100% represent fluorescence intensity of the
discs in Tris/NaCl.
PAR release from the hydrogels was then followed during 72
h in microbiological growth medium (MH) or cell culture
medium (DMEM). PAR-FITC-loaded hydrogels were placed
into these media and incubated at 37 °C, and PAR release was
observed by confocal microscopy (Figure 4C). The release was
faster for PAR10 in MH, compared to PAR30 and PAR200,
which were released more gradually (Figure 4D). In DMEM,
all three PAR had more or less similar release profiles and were
completely released after 48 h (Figure 4E).
Antibacterial Activity of HA-PAR Hydrogels. After
showing that HA hydrogels can be loaded with PAR, which is
released in microbiological growth medium and cell culture
medium, we tested antibacterial activity of HA-PAR hydrogel
toward S. aureus as our model and because its presence is
widely reported in implant-related nosocomial infections. At
high-loading PAR concentrations (incubation in 1 mg·mL−1
PAR solutions), all three PAR inhibited S. aureus bacteria
growth after 24 h (Figure S4). However, high concentration of
loaded PAR might be toxic to the mammalian cells. To
evaluate antibacterial properties of HA-PAR hydrogels in more
details, we performed repetitive bacterial culture in the
presence of HA hydrogel discs incubated in different
concentrations of PAR. HA-PAR discs were incubated with
bacterial suspension for 24 h, and then bacteria suspension was
replaced every 24 h (Figure S1). This was done to mimic the
worst conditions of repetitive bacterial infections, for example,
in case of urinary or venous catheter-associated infections.
Hydrogels incubated in 0.05 mg·mL−1 of PAR10 and PAR30
solutions showed 1 and 2 days of antibacterial activity,
respectively. Hydrogels incubated in 0.1 mg·mL−1 of PAR10
and PAR30 solutions showed 2 and 4 days of antibacterial
activity, respectively. For higher PAR10 and PAR30 concen-
trations (incubation in 0.5 mg·mL−1 of PAR solutions),
antibacterial activity lasted for 6 and 7 days, respectively
(Figure 5A,B).
Interestingly, PAR10 loaded into HA hydrogel showed
antibacterial effect, which was not the case in the PAR10/HA
thin film, while in solution, all three PAR showed antibacterial
activity.23 However, antibacterial effect of PAR30 was more
prolonged, compared to PAR10, which is probably because of
slower release of PAR30 from the hydrogels. This correlates
with PAR10 and PAR30 mobility inside the hydrogels (PAR10
being more mobile) (Figure 3D), and with release profiles
(Figure 4D).
For hydrogels incubated in 0.5 mg·mL−1 PAR200 solution,
some bacterial growth was already observed after 24 h, and the
antimicrobial efficiency of the hydrogel decreased every
following days (Figure 5C). Thus, PAR200 was much less
efficient at equal w/v concentration when compared to PAR10
and PAR30. This can be because of its incomplete release from
the hydrogels (Figure 4), in addition to its higher minimum
inhibitory concentration (MIC) of 0.210 mg·mL−1, as
described previously.23 MICs of PAR10 and PAR30 in solution
(0.02 and 0.01 mg·mL−1, respectively) combined with their
higher released amounts can explain the high antibacterial
activity of PAR10- and PAR30-loaded hydrogels.
According to Figure 4, about 218 μg of PAR10 was released
after 72 h in NaCl. This quantity in a total volume of 0.4 mL of
MH medium would correspond to a concentration of 0.545
mg·mL−1, which is more than 20 times higher than MIC10. For
PAR30, 200 μg was released after 72 h in NaCl, corresponding
to a concentration of 0.5 mg·mL−1, which is almost 50 times
higher than MIC30. Thus, hydrogels contain enough PAR to
inhibit bacterial growth for several days. When PAR30 is
released gradually, like in case of its release in MH (Figure
4C,D), it may provide, in theory, up to 40 days of antibacterial
activity. In reality, after 72 h, 80% of PAR30 is released (Figure
4D). However, the remaining 20% correspond to approx-
imately 40 μg of PAR30. If released into the medium (400 μL),
it would give a concentration of 100 μg.mL−1, which is 10
times higher than MIC. Thus, the remaining quantity is
sufficient for several more days of antibacterial activity in MH
medium. We have performed repetitive culture for up to 7
days, and no bacterial growth was observed for HA-PAR30
hydrogels incubated in 0.5 mg·mL−1 PAR30 solution.
Finally, we also tested if PAR30-loaded hydrogels can inhibit
growth of other bacterial strains such as E. coli and P.
aeruginosa, both Gram-negative bacteria which are responsible,
together with Gram-positive S. aureus, of the majority of
nosocomial infections. The antibacterial effect toward Gram-
negative bacteria was observed at PAR30-loading concen-
trations equal to 0.1 mg·mL−1 and higher (Figure S5). For
Figure 5. Antibacterial activity of HA hydrogels loaded with PAR10,
PAR30, PAR200: repetitive culture. Every 24 h of bacterial culture,
the samples were seeded with fresh bacteria. The graphs show
bacterial growth in the presence of hydrogel discs loaded with PAR10
(A), PAR30 (B), and PAR200 (C). Data were normalized, and 100%
corresponds to bacterial growth in the wells without hydrogels. The
graphs represent averages from three independent experiments, and
error bars represent standard deviations.
loading concentrations of 0.5 and 1 mg·mL−1, the antibacterial
effect lasted for 3 days in the repetitive in vitro infection model.
Biocompatibility of HA-PAR Hydrogels. For use in
clinical applications, antibacterial HA-PAR hydrogels have to
be biocompatible. As a first step toward evaluation of HA-PAR
hydrogel biocompatibility, we performed the in vitro direct
cytotoxicity test (Figure S2), according to the ISO 10993-5
norm. Balb/3T3 fibroblasts were observed through microscopy
after 24 h of incubation with hydrogel discs in DMEM
medium, unloaded or loaded with 0.05 and 0.1 mg·mL−1 of
PAR10 and PAR30, as well as 0.5 mg·mL−1 of PAR200. These
concentrations correspond to the lowest antibacterial loading
concentrations for each PAR (Figure 5). Confluent cell layers
for the control, PAR10, and PAR30 (Figure 6A) were
observed. However, in the condition where HA hydrogel was
loaded with 0.5 mg·mL−1 PAR200, only rounded cells and
cellular debris could be seen, suggesting cytotoxic effect of the
aforementioned hydrogel.
These observations were confirmed by MTT test results: for
unloaded hydrogels or those loaded with 0.05 and 0.1 mg·
mL−1 of PAR10 and PAR30, cell viability was above 70%
(100% corresponding to untreated cells), indicating the
absence of cytotoxicity, according to ISO 10993-5 (Figure
6B). Condition in which the cells were incubated with 0.5 mg·
mL−1 PAR200-loaded hydrogel showed decreased viability
(43%) and was therefore considered as cytotoxic. PAR10- and
PAR30-loading concentrations superior to 0.1 mg·mL−1 also
showed cytotoxic response; however, these concentrations are
significantly higher than the necessary concentration needed to
provide robust antimicrobial activities (Figure S6).
According to Figure 4E, the total release of PAR in DMEM
takes 48 h, therefore we checked cell viability after 24 and 48 h
of incubation with HA-PAR hydrogels. The results showed
that cell viability for PAR10 and PAR30-loaded hydrogels was
similar or even higher after 48 h as compared to 24 h, with
some viability decrease for PAR200 (Figure S7).
HA-PAR Hydrogel Deposition on Medical Devices.
After demonstrating the antimicrobial activity of PAR-loaded
HA hydrogels, we evaluated the possibility to associate them to
medical materials used for clinical applications. We selected a
nonwoven fabric used for wound cleaning and dressing
(hydrophilic gauze made of 70% viscose and 30% polyester)
and a polypropylene (PP) mesh used for treatment of
urogynecological pathologies42 (Figure 7A−C). HA hydrogels
were successfully deposited onto both materials and showed
antibacterial activity similar to HA hydrogel discs (Figure S8)
after loading with PAR. Moreover, HA-PAR hydrogels
deposited onto mesh prosthesis, dried, and sterilized by
autoclaving, showed similar antibacterial activity as compared
to nonsterilized samples (Figure 7D). Thus, HA-PAR
hydrogels can be easily deposited onto wound cleaning/
dressing materials to prevent or fight infection on the body
surface but also integrated into implantable mesh materials to
reduce the risk of implantation-related infection.
In Vivo Biocompatibility Assessment. Preliminary in
vivo experiments were conducted on rats (10 animals). Each
rat received two implants of hydrogel-coated meshes (d = 1
cm), one implant on the left side and one implant on the right
side (Figure 7E). All animals survived the duration of the study
with no adverse effects, and all animals gained weight in a
normal way. After 14 days, the implants with the surrounding
tissue were explanted and collected to perform histological
analysis. An example of the histological sample is shown in
Figure 7F. The results of the analysis showed the presence of
inflammation in the tissues surrounding the implants (Figure
S9 and Table S1). However, there was no difference between
HA-only hydrogels and HA-PAR hydrogels, suggesting that
PAR addition does not promote or increase inflammatory
response. As described before, BDDE-crosslinked HA hydro-
gels are regularly used as the dermal filler, and if such a limited
inflammation occurs, it has never been reported as being
problematic. A future in vivo study confirming these results
and including an infectious model should be planned to
confirm the strong potential of this HA/PAR hydrogel for
medical applications.
■ CONCLUSIONS
Because of the growing antibiotic resistance, new antibacterial
agents are required, as well as new materials that can be
Figure 6. Cytotoxicity assay: Balb/3T3 cells are seeded in the 24-well
plate and put in contact with HA hydrogel discs loaded or not with
PAR for 24 h. “HA” corresponds to BDDE-crosslinked HA hydrogel
discs without PAR, and other hydrogels were loaded with indicated
PAR at different concentrations. (A) Cell morphology observed by
phase contrast microscopy. (B) Cell viability evaluation by MTT test.
Dotted line corresponds to 70% viability (cytotoxicity limit according
to ISO standard 10993-5). The graphs represent averages from three
independent experiments, and error bars represent standard
deviations. *p = 0.05, **p < 0.01.
deposited onto medical devices and allowing to control the
release of antimicrobial agents. In this work, we introduced a
unique and simple formulation of HA-based antimicrobial
material. We developed negatively charged HA hydrogels
which, via electrostatic interaction, can absorb high quantities
of positively charged antimicrobial agent PAR. Such for-
mulation provides a prolonged antibacterial effect in vitro
because of the gradual release of PAR. Among three different
tested PAR lengths, PAR with 30 residues (PAR30) showed
the most prolonged antibacterial effect in a repetitive infection
in vitro model, providing at least one-week of antibacterial
activity against Gram-positive S. aureus, the pathogen leading
to multiple hospital-associated infections. HA-PAR30 hydro-
gels were also efficient against Gram-negative bacteria E. coli
and P. aeruginosa.
The hydrogels can be tuned in terms of their size, quantities
of loaded PAR, and their release kinetics. In addition, both
PAR10 and PAR30-loaded antibacterial hydrogels with 2−4
days of antibacterial activity showed good in vitro biocompat-
ibility. The hydrogels were successfully deposited on medical
devices like fabrics or meshes used in clinical applications
(Medicomp and Gynecare Gynemesh), and antibacterial
Figure 7. Deposition of HA hydrogels on medical devices. (A) Medicomp was cut into 12 mm diameter pieces and embedded with the HA
hydrogel. (B) Gynecare Gynemesh was cut into 12 mm diameter pieces and embedded with the HA hydrogel. (C) Confocal microscopy image of
PAR30-FITC-loaded HA hydrogels deposited onto Gynecare Gynemesh. (D) Effect of autoclaving on antibacterial activity of HA-PAR hydrogels.
Hydrogels were deposited onto PP mesh prosthesis, loaded with 0.05 and 0.1 mg·mL−1 of PAR10 and PAR30 and autoclaved at 121 °C for 20 min.
The graphs show bacterial growth in the presence of hydrogels after 24 h of incubation at 37 °C; 100% corresponds to a positive control (bacteria
grown in absence of HA-PAR hydrogels). (E) Rat implantation sites. (F) Example of histological cross-sections of the explants showing the
implanted hydrogel and the surrounding tissues. The hydrogel is marked by an asterisk.
activity of the resulting constructs was preserved after drying
and autoclaving, which is important for its potential use in
clinics.
Finally, we performed first in vivo tests of hydrogel-coated
mesh material biocompatibility in a rat model, which showed
no difference between control HA hydrogel and PAR-loaded
hydrogel. The next step of our work will be related to further in
vivo studies of hydrogel biocompatibility, as well as their
antibacterial activity in the infected model.
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